Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema

Fig. 2

Mean visual acuity measurements in group 1 throughout study. A chart illustrating mean logMAR visual acuity in group1 and subgroups 1A and 1B through 18 months of sustained same agent anti-VEGF treatment. Data were collected at baseline, and after 3, 6, 12 and 18 months. P1 = p value in group 1, P2 = p value in subgroup 1A, P3 = p value in subgroup 1B

Back to article page